Massachusetts General Hospital: Immune Therapy Takes a 'BiTE' Out of Brain Cancer
July 24, 2019
July 24, 2019
BOSTON, Massachusetts, July 24 -- Massachusetts General Hospital issued the following news:
* * *
- A Method Combining Two Distinct Immune System-Based Treatments May Help to Improve Outcomes for Patients with Glioblastomas and Other Solid Tumors.
* * *
Building on their research showing that an exciting new form of immunotherapy for cancer has activity in patients with glioblastoma, the most common and most deadly form of brain cancer, Massach . . .
* * *
- A Method Combining Two Distinct Immune System-Based Treatments May Help to Improve Outcomes for Patients with Glioblastomas and Other Solid Tumors.
* * *
Building on their research showing that an exciting new form of immunotherapy for cancer has activity in patients with glioblastoma, the most common and most deadly form of brain cancer, Massach . . .